Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 14Recruiting 8Active not recruiting 5Unknown 4Terminated 3Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 993Neoplasms 852Carcinoma, Non-Small-Cell Lung 844Prostatic Neoplasms 528Neoplasm Metastasis 501Leukemia, Myeloid, Acute 489Melanoma 456Colorectal Neoplasms 447Multiple Myeloma 441Lung Neoplasms 421Pancreatic Neoplasms 353Recurrence 350Lymphoma 350Ovarian Neoplasms 341Lymphoma, Non-Hodgkin 329Leukemia 324Leukemia, Lymphocytic, Chronic, B-Cell 302Precursor Cell Lymphoblastic Leukemia-Lymphoma 271Carcinoma, Renal Cell 256Head and Neck Neoplasms 246Brain Neoplasms 245Carcinoma, Hepatocellular 234Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Myelodysplastic Syndromes 230Lymphoma, Large B-Cell, Diffuse 228Lymphoma, Follicular 219Colonic Neoplasms 191Stomach Neoplasms 182Rectal Neoplasms 175

Interventions

indusatumab 1Cetuximab 1Anesthesia, General 1Anesthesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Pancreatic Adenocarcinoma × Clear all
NCT04992507 2025-07-10

Impact of Total Intravenous Anesthesia Following Cancer Surgery, TIVACS Study

Ohio State University Comprehensive Cancer Center

Phase 2 Terminated
8 enrolled 7 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02736578 2019-06-25

Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery

Stanford University

Phase 2 Terminated
8 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

NCT02202785 2017-05-15

A Study of MLN0264 in Patients With Pancreatic Cancer

Takeda

Phase 2 Terminated
43 enrolled 22 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡